Leo Rasche
@RascheLeo
Followers
327
Following
332
Statuses
67
Joined October 2022
RT @haas_lab: How does multiple myeloma progress? In our latest @SciImmunology cover story, we reveal how myeloma cells breaking through bo…
0
11
0
RT @HDMyeloma: 📣 We are excited to announce the 10th Heidelberg Myeloma Workshop Join us on April 25–26, 2025, as international & local e…
0
12
0
RT @ElizSMcKenna: Now online in @CD_AACR: Prenatal Exposure to Chemotherapy Increases the Mutation Burden in Human Neonatal Hematopoietic S…
0
17
0
RT @ESHaematology: 📣 #ESHMM2025 ONLY 4 DAYS LEFT TO SUBMIT YOUR ABSTRACT OR CLINICAL CASE Proceed now ➡ 5th How to…
0
3
0
RT @BloodJournal: BCMA bispecifics: breaking the chains of resistance #immunobiologyandimmunotherapy
0
17
0
RT @RahulBanerjeeMD: #ASH24 just for context - in DETERMINATION published just a few years ago, MRD neg (10^-5) AFTER ASCT was ~54%. In Ma…
0
8
0
RT @MJSteinhardt: Happy to finally see this published! Heartfelt congratulations to Mara for the hard work and big thanks to @RascheLeo fo…
0
4
0
RT @Uniklinikum_Wue: Die AGs von Angela Riedel und Leo Rasch @MSNZ_wuerzburg haben es mit ihrer detaillierten Analyse von extramedullären L…
0
2
0
RT @majorajay: New in @NEJM: 7/67 pts who received eli-cel developed heme malignancies, all MDS or AML. All cases were d/t clonal vector in…
0
18
0
RT @HDMyeloma: we are deeply grateful to our patients, & send a big thanks to all co-authors, & everyone who supported this work. @RascheLe…
0
1
0
RT @AlGarfall: Proud to have contributed to this commentary led by Niels van de Donk along with @SurbhiSidanaMD @RascheLeo @SonjaZweegman @…
0
12
0
RT @Rfonsi1: HDP-101 BCMA ADC Amanitin is a RNA polymerase 2 inhibitor. Small numbers but they see PR and even one CR
0
5
0
RT @BloodCancerJnl: Sustained remission following finite duration bispecific antibody therapy in patients with relapsed/refractory myeloma.…
0
18
0
RT @BloodJournal: Efficacy of CAR T-cell therapy is not impaired by previous bispecific antibody treatment in large B-cell lymphoma https:/…
0
39
0
RT @NBahlis: Excellent review on myeloma novel immune therapies by Drs Kenneth Anderson, Paola Neri, @NoemieLeblay @hollyleeYJ and Annamari…
0
11
0
RT @bdermanmd: Intriguing data from MajesTEC-7 (Tec-Dara-R) safety-run in. First off: Dara-Rd lead in before adding teclistamab led to high…
0
11
0
RT @matteoclaudio84: New preprint! We are happy to share the first preprint from @nickbolli Lab! Here we depict for the first time the tran…
0
15
0
RT @DrGarethMorgan1: Our latest work on phf19 and high risk myeloma congrats Brian and Travis @nyulangone
0
4
0